Skip to main content
Caplight Logo









Novelogics Biotechnology

Novelogics Biotechnology

Private
VancouverHealthcare & Life Scienceshttps://novelogics.com/

Company Overview

Novelogics Biotechnology is a biotechnology company that develops monoclonal antibody immunotherapy drugs for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibodyimmunotherapycancer treatmentoncologydrug discoverypreclinical biotechimmuno-oncologyantibody drugbiopharmaimmune evasionlife sciencesbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novelogics Biotechnology Comparables

Compare Novelogics Biotechnology with similar companies based on industry and business-model similarity.

Novelogics Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AKSO Biopharmaceutical
82%
Aakha Biologics
81%
Biosion, Inc.
78%

Novelogics Biotechnology Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Elaine Allison

Co-Founder, CEO

Founding Team

Novelogics Biotechnology Filings

Explore SEC and related filing metadata, where available.

Novelogics Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novelogics Biotechnology's valuation, stock price, and market status.

Is Novelogics Biotechnology a public or private company?

Novelogics Biotechnology is a private company.

What is the current stock price of Novelogics Biotechnology?

Novelogics Biotechnology is a private company with no public stock price. Caplight tracks Novelogics Biotechnology's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Novelogics Biotechnology worth (valuation)?

Valuation information for Novelogics Biotechnology is not publicly available.

Can I buy Novelogics Biotechnology stock?

Novelogics Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novelogics Biotechnology's last funding round?

Funding round information for Novelogics Biotechnology is not publicly available.

Who are the main investors in Novelogics Biotechnology?

Investor information for Novelogics Biotechnology is not publicly disclosed.

Will Novelogics Biotechnology IPO soon?

No public IPO plans have been announced for Novelogics Biotechnology.

How can I track Novelogics Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novelogics Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVancouver
Employee Range1
Year Founded2013
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?